“…2 ) [ 22 ]. Subcutaneous edema and skin thickening can also occur and are generally symmetrical [ 23 ]. Fig.…”
Section: Ct Findings Of Normal Postmortem Changementioning
confidence: 99%
“…Postmortem CT imaging can be used to elucidate bony lesions, such as the presence or absence of fractures and osteoplastic or osteolytic changes (Fig. 5 ) [ 23 ]. Additionally, postmortem CT imaging can reveal subcutaneous edema, large peripheral lacerations, and soft tissue hematomas [ 76 ].…”
Section: Diagnosable or Non-diagnosable Pathology On Non-contrast-enh...mentioning
confidence: 99%
“…The ability to identify findings that may not be easily detected through traditional dissection methods, such as bony lesions. In some cases, postmortem CT may be sufficient to omit skeletal dissection during the subsequent autopsy [ 23 ].…”
Section: Benefits Of Postmortem Ct For Pathologic Autopsy In In-hospi...mentioning
Postmortem computed tomography (CT) is an essential tool for investigating the causes of death. Postmortem CT has characteristic imaging findings and should not be interpreted in the same manner as clinical antemortem images. In analyzing the cause of death in in-hospital death cases using postmortem images, it is crucial to understand early postmortem and post-resuscitation changes. In addition, it is essential to understand the limitations of diagnosing the cause of death or significant pathology relating to death on non-contrast-enhanced postmortem CT. In Japan, there has also been social demand to establish a system for postmortem imaging at the time of death. To facilitate such a system, clinical radiologists should be prepared to interpret postmortem images and assess the cause of death. This review article provides comprehensive information regarding unenhanced postmortem CT for in-hospital death cases in daily clinical practice in Japan.
“…2 ) [ 22 ]. Subcutaneous edema and skin thickening can also occur and are generally symmetrical [ 23 ]. Fig.…”
Section: Ct Findings Of Normal Postmortem Changementioning
confidence: 99%
“…Postmortem CT imaging can be used to elucidate bony lesions, such as the presence or absence of fractures and osteoplastic or osteolytic changes (Fig. 5 ) [ 23 ]. Additionally, postmortem CT imaging can reveal subcutaneous edema, large peripheral lacerations, and soft tissue hematomas [ 76 ].…”
Section: Diagnosable or Non-diagnosable Pathology On Non-contrast-enh...mentioning
confidence: 99%
“…The ability to identify findings that may not be easily detected through traditional dissection methods, such as bony lesions. In some cases, postmortem CT may be sufficient to omit skeletal dissection during the subsequent autopsy [ 23 ].…”
Section: Benefits Of Postmortem Ct For Pathologic Autopsy In In-hospi...mentioning
Postmortem computed tomography (CT) is an essential tool for investigating the causes of death. Postmortem CT has characteristic imaging findings and should not be interpreted in the same manner as clinical antemortem images. In analyzing the cause of death in in-hospital death cases using postmortem images, it is crucial to understand early postmortem and post-resuscitation changes. In addition, it is essential to understand the limitations of diagnosing the cause of death or significant pathology relating to death on non-contrast-enhanced postmortem CT. In Japan, there has also been social demand to establish a system for postmortem imaging at the time of death. To facilitate such a system, clinical radiologists should be prepared to interpret postmortem images and assess the cause of death. This review article provides comprehensive information regarding unenhanced postmortem CT for in-hospital death cases in daily clinical practice in Japan.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
